3309.HK

C-MER Eye Care Holdings Limited [3309.HK] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?

3309.HK Stock Summary

Earnings have grown 11.09% per last year.

In the News

3309.HK Financial details

Company Rating

Market Cap

3.62B

Income

40.12M

Revenue

3.66B

Book val./share

Cash/share

Dividend

Dividend %

Employees

3.27K

Optionable

Shortable

Yes

Earnings

26 Mar 2024

P/E

-88.03

Forward P/E

PEG

3.16

P/S

2.38

P/B

2.18

P/C

P/FCF

55.95

Quick Ratio

1.33

Current Ratio

1.63

Debt / Equity

LT Debt / Equity

EPS (TTM)

0.03

EPS next Y

EPS next Q

EPS this Y

-379.1%

EPS next Y

EPS next 5Y

EPS last 5Y

4.52%

Revenue last 5Y

27.27%

Revenue Q/Q

2.47%

EPS Q/Q

8.9%

SMA20

SMA50

SMA100

Inst Own

Inst Trans

ROA

-2%

ROE

-3%

ROC

0.02%

Gross Margin

26%

Oper. Margin

Profit Margin

-3%

Payout

Shs Outstand

Shs Float

Target Price

52W Range

2.39-4.79

52W High

-55.5%

52W Low

-11%

RSI

Rel Volume

0.41

Avg Volume

884.11K

Volume

360K

Perf Week

3.49%

Perf Month

4.71%

Perf Quarter

-11%

Perf Half Y

-13.17%

Beta

0.606

Volatility

0.02%, 0.03%

Prev Close

0.56%

Price

1.78

Change

1.71%

Something similar

Top by Market Cap

Same Sector

Same Price Range

Similar Market Cap

Company Profile

Volume Average 884.11K
Market Capitalization 3.62B
Employee 3.27K
CEO Dr. Shun Chiu Lam J.P.
Headquarters Central,HK
IPO Date 2018-01-15
Website https://www.cmereye.com

C-MER Eye Care Holdings Limited, an investment holding company, provides ophthalmic services under the C-MER Dennis Lam brand name in Hong Kong and Mainland China. The company operates eye and surgery centers, and satellite clinics that provide cataract and intraocular lens implant, refractive correction, corneal and external eye disease, glaucoma, vitreo-retinal disease, oculoplastic and orbital disease, and squint and pediatric ophthalmology services. It also sells vision aid and pharmaceutical products, as well as dental services. The company was founded in 2012 and is headquartered in Central, Hong Kong. C-MER Eye Care Holdings Limited is a subsidiary of C-MER Group Limited.